Valuation Ribomic Inc.

Stocks

Market Closed - Japan Exchange 02:30:00 2026-09-11 EDT			5-day change	1st Jan Change
80.00 ^JPY	-2.44%		-5.88%	+2.56%

08-24	Ribomic Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia	CI
08-13	Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	10,159	5,997	6,710	3,318	4,370	4,779
Change	-	-40.96%	11.89%	-50.56%	31.71%	9.37%
Enterprise Value (EV) ¹	4,321	1,296	2,385	-81.19	1,333	1,952
Change	-	-69.99%	83.99%	-103.4%	1,741.55%	46.47%
P/E	-7.88x	-3.5x	-3.54x	-3.24x	-3.89x	-3.82x
PBR	1.69x	1.28x	1.53x	0.99x	1.44x	1.68x
PEG	-	-0.1x	0.3x	0.1x	0.3x	0.45x
Capitalization / Revenue	112x	75x	103x	-	2,185x	1,593x
EV / Revenue	47.5x	16.2x	36.7x	-	666x	651x
EV / EBITDA	-3.56x	-0.75x	-1.34x	0.07x	-1.27x	-1.62x
EV / EBIT	-3.48x	-0.74x	-1.33x	0.07x	-1.27x	-1.62x
EV / FCF	-5.69x	-1.38x	-1.97x	0.13x	-1.89x	-2.57x
FCF Yield	-17.6%	-72.4%	-50.8%	793%	-52.8%	-38.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-46.16	-59.92	-53.14	-28.69	-25.19	-23.06
Distribution rate	-	-	-	-	-	-
Net sales ¹	91	80	65	-	2	3
EBITDA ¹	-1,214	-1,734	-1,787	-1,106	-1,049	-1,204
EBIT ¹	-1,240	-1,749	-1,787	-1,116	-1,050	-1,207
Net income ¹	-1,187	-1,684	-1,653	-1,024	-1,018	-1,145
Net Debt ¹	-5,838	-4,701	-4,325	-3,399	-3,037	-2,827
Reference price ²	364.00	210.00	188.00	93.00	98.00	88.00
Nbr of stocks (in thousands)	27,909	28,559	35,693	35,675	44,590	54,309
Announcement Date	6/30/21	6/29/22	6/28/23	6/26/24	6/20/25	6/19/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RIBOMIC INC.	-	-	-	-	29.46M
WUXI APPTEC CO., LTD.	19.64x	6.93x	13.92x	1.51%	66.93B
ARGENX SE	31.94x	9.24x	44.54x	0.04%	61.97B
INSMED INCORPORATED	-79.21x	15.29x	-73.77x	-.--%	28.26B
WUXI BIOLOGICS (CAYMAN) INC.	28.46x	6.03x	15.64x	-.--%	24.59B
BIONTECH SE	-14.63x	5.3x	-6.66x	-.--%	24.3B
GENMAB A/S	26.45x	4.98x	16.56x	-.--%	19.41B
PHARMAESSENTIA CORPORATION	48.28x	17.79x	36.09x	0.31%	16.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1225.47x	35.26x	769.42x	-.--%	14.18B
SUMMIT THERAPEUTICS INC.	-15x	3382.33x	-17.29x	-.--%	14B
Average	141.27x	387.02x	88.72x	0.21%	27.04B
Weighted average by Cap.	73.54x	184.88x	49.64x	0.4%